ClinicalTrials.gg

Program

Pyridoxine

Also written as “Doxylamine + Pyridoxine” and “Vitamin B12, Vitamin B6, Folic acid”.

Its studies are mostly in Nausea · Vitamin B 12 Deficiency, led by 2 companies.

Furthest: phase 4, since Mar 11, 20243 company-led studies, 0 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Valenta Pharm JSC20 open or runningphase 1since Mar 11, 2024Aug 9, 2022none ahead
Medice Arzneimittel Pütter GmbH & Co KG10 open or runningphase 4since May 1, 2025May 1, 2025none ahead

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Aug 9, 2022First study: no phase study in NauseaNew to Valenta Pharm JSCValenta Pharm JSC · NCT05498233 · 28 enrolled · Russian Federation
  2. Mar 11, 2024Phase 1 study in NauseaValenta Pharm JSC · NCT06342778 · 28 enrolled · Russia
  3. May 1, 2025Medice Arzneimittel Pütter GmbH & Co KG's first study: phase 4 study in Vitamin B 12 DeficiencyNew to Medice Arzneimittel Pütter GmbH & Co KGMedice Arzneimittel Pütter GmbH & Co KG · NCT07029698 · 46 enrolled · Ukraine

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 3 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusLed byPrimary completionSize
NCT07029698Vitamin B 12 Deficiency · Ukraine4CompletedMedice Arzneimittel Pütter GmbH & Co KGOct 7, 202546
NCT06342778Nausea · Russia1CompletedValenta Pharm JSCMay 2, 202428
NCT05498233Nausea · Russian Federation–CompletedValenta Pharm JSCSep 19, 202228

How it is read

Names in the registry

  • “Doxylamine + Pyridoxine”, 2 entries
  • “Vitamin B12, Vitamin B6, Folic acid”, 1 entry

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.